| Fazila Khan, MD | |
|
501 Bath Rd, Bristol, PA 19007-3190 | |
| (215) 785-9977 | |
| (215) 785-9216 |
| Full Name | Fazila Khan |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 501 Bath Rd, Bristol, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790421345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MT225308 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fazila Khan, MD 501 Bath Rd, Bristol, PA 19007-3190 Ph: (215) 785-9977 | Fazila Khan, MD 501 Bath Rd, Bristol, PA 19007-3190 Ph: (215) 785-9977 |
News Archive
Many women in the WHO European Region, particularly those in their 40s, are diagnosed at a late stage of HIV infection when their immune system is already starting to fail. They are three to four times more likely to be diagnosed late than younger women.
Amgen and Merck, known as MSD outside the U.S. and Canada, today announced an expanded collaboration to evaluate the efficacy and safety of talimogene laherparepvec, Amgen's investigational oncolytic immunotherapy, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in a Phase 1, open-label trial of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).
As in other countries, the Australian health care system has limited capacity to rapidly move a future treatment for Alzheimer's disease from approval into wide clinical use, which could leave thousands of older people without access to transformative care if such a breakthrough occurs, according to a new study by RAND Australia.
Today, the International and American Associations for Dental Research published a paper titled "Global Burden of Oral Conditions in 1990-2010: A Systemic Analysis." The paper, written by lead author Wagner Marcenes, Queen Mary University, London, is published in the IADR/AADR Journal of Dental Research.
BARRX Medical, Inc., a leader in developing minimally invasive medical devices to remove precancerous tissue from the gastrointestinal tract, reported today that the American Gastroenterological Association has issued the AGA Medical Position Statement on the Treatment of Barrett's Esophagus.
› Verified 5 days ago
Angelo J Ratini, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Bath Rd Ste 209a, Bristol, PA 19007 Phone: 215-785-9830 Fax: 215-785-9822 | |
Dr. Fenil Gandhi, MD/MHA Family Medicine Medicare: Medicare Enrolled Practice Location: 501 Bath Rd, Bristol, PA 19007 Phone: 929-464-6232 | |
John Demario, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 Bath Rd, Bristol, PA 19007 Phone: 845-238-0131 | |
Bernard Okem Ogon, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1303 Veterans Hwy, Bristol, PA 19007 Phone: 215-458-7114 | |
Dr. Alexandra Jillian Brown, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 501 Bath Rd, Bristol, PA 19007 Phone: 215-785-9200 | |
Scarlett Patricia Somarriba, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 501 Bath Rd, Bristol, PA 19007 Phone: 215-785-9977 | |
Dr. John Charles Pickard, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 642 Beaver St, Bristol, PA 19007 Phone: 215-785-2626 Fax: 215-785-2665 |